Atossa Therapeutics, Inc.’s Post

The top regional #healthcare and #biotech news for December 11th via the Big4Bio newsletters: San Diego: AnaptysBio's Mid-Stage Failure; Iambic Therapeutics Names CSO; More on Cardiff Oncology https://lnkd.in/gMvC6jS8 SF Bay: Exec Hires; Alveo Technologies, CareDx, Inc. Strike Deals; The Bio Report Podcast https://lnkd.in/gEKpNTGy Seattle: Allen Institute Leadership Change; Atossa Therapeutics, Inc. Endoxifen's Phase 2 Success; Hot Investor Profiles https://lnkd.in/g7hnN7-E Los Angeles: Angitia Biopharmaceuticals Secures $120M; ACELYRIN, INC.'s Phase 2b/3 Uveitis Treatment Insights; Arrowhead Pharmaceuticals' Clinical Progress https://lnkd.in/g5r93fZP Boston: nChroma Bio Forms; uniQure Stock Doubles; Compass Therapeutics Inc. Hires CFO; Syncell Inc Raises $15M https://lnkd.in/gp4HyZGn Philadelphia: The Wistar Institute Wins Two Grants; Orphan Tag for Pilatus Biosciences; More on Carisma Therapeutics https://lnkd.in/gzWDwjvn Capital Region: Novavax Branches Out; Protaryx Medical Completes First-in-Human Study; TransThera | 药捷安康 Shows Results https://lnkd.in/gchY5auY NYC: Kashiv BioSciences LLC Hires Execs; Cellectar Biosciences, Inc. Lays Off 60%; Hepion Pharmaceuticals, Pharma Two B Call It Quits; Negev Labs Launches https://lnkd.in/gT-evJy3